Dalfampridine Tablet, Extended Release
Product Images NDC 62756-429

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 62756-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-dalfampridine-figure1 (Spl Dalfampridine Figure1)

A bar chart showing the average percent increase in walking speed from baseline among patients treated with placebo (N=72) and Dalfampridine 10 mg b.i.d. (N=224). The x-axis represents different thresholds of percent increase (≥0%, ≥10%, ≥20%, ≥30%, ≥40%, ≥50%, ≥60%), and the y-axis represents the percentage of patients achieving these increases.*

FDA Label Image

Spl-dalfampridine-figure2 (Spl Dalfampridine Figure2)

A bar chart comparing the percentage of patients achieving various average percent increases in walking speed from baseline. It shows data for two groups: placebo (N=118) and Dalfampridine 10 mg twice daily (N=119), with the Dalfampridine group having higher percentages of patients at each increase threshold, illustrated by grouped bars for increments from ≥0% to ≥60%.*

FDA Label Image

Spl-dalfampridine-formula (Spl Dalfampridine Formula)

A mathematical formula illustrating the calculation of creatinine clearance (Crcl) based on age, weight, serum creatinine, and a constant factor of 72.*

FDA Label Image

Spl-dalfampridine-label (Spl Dalfampridine Label)

Label for Dalfampridine Extended-Release Tablets 10 mg by Sun Pharmaceutical Industries, Inc. The label includes the NDC 62756-429 and indicates a quantity of 60 tablets. It instructs pharmacists to dispense with a medication guide to each patient. The label also features a barcode and the Sun Pharma logo.*

FDA Label Image

Spl-dalfampridine-structure (Spl Dalfampridine Structure)

Chemical structure of dalfampridine, showing a six-membered ring with one nitrogen atom and an attached amino group (NH2). This structure represents the active ingredient dalfampridine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.